RAAS

RAAS

6 min read Updated Mar 26, 2026

RAAS is the body’s emergency blood pressure rescue system. When blood pressure drops - from dehydration, hemorrhage, or heart failure - the kidneys detect the problem and launch a hormonal cascade that raises blood pressure through multiple simultaneous mechanisms. Understanding every step of this cascade is essential for the MCAT.

The RAAS Cascade: Step by Step

Step 1: Trigger - low blood pressure detected
The JG cells of the afferent arteriole sense reduced renal perfusion (low blood pressure). Three signals activate renin release:

  • Direct detection of low pressure by baroreceptors in the afferent arteriole
  • Low NaCl detected by the macula densa (signals low GFR)
  • Sympathetic nervous system activation (beta-1 receptors on JG cells)

Step 2: Renin release
JG cells secrete renin (an enzyme) into the blood.

Step 3: Angiotensinogen to Angiotensin I
Renin cleaves angiotensinogen (a large protein continuously produced by the liver) into angiotensin I. Angiotensin I is inactive - it is just an intermediate.

Step 4: Angiotensin I to Angiotensin II
Angiotensin-converting enzyme (ACE), located primarily on the endothelial surface of pulmonary capillaries (lungs), converts angiotensin I into angiotensin II. ACE also degrades bradykinin (a vasodilator), which explains the dry cough side effect of ACE inhibitors.

Step 5: Angiotensin II - the effector
Angiotensin II is one of the most potent vasoconstrictors in the body, playing a central role in blood pressure regulation. It has multiple simultaneous effects:

EffectMechanismSpeed
VasoconstrictionContracts arteriolar smooth muscleImmediate (seconds)
Aldosterone releaseStimulates zona glomerulosa of adrenal cortexMinutes to hours
ADH releaseStimulates posterior pituitaryMinutes
ThirstStimulates hypothalamic thirst centerMinutes
Na+ reabsorptionDirect action on PCT (stimulates Na+/H+ exchange)Minutes
Efferent arteriole constrictionPreferentially constricts efferent arteriole, raising GFRImmediate
RAAS flowchart: low BP triggers renin, which converts angiotensinogen to angiotensin I, ACE converts it to angiotensin II, causing vasoconstriction, aldosterone release, and ADH secretion
The RAAS cascade. Focus on: low BP → renin (from JG cells) → angiotensinogen → angiotensin I → (ACE in lungs) → angiotensin II → vasoconstriction + aldosterone (Na+ reabsorption) + ADH (water reabsorption) + thirst. ACE inhibitors and ARBs are common drug targets. Credit: Wikimedia Commons, CC BY-SA 4.0

Pharmacological Targets in the RAAS

The MCAT commonly describes drugs that target specific steps in the RAAS cascade:

ACE inhibitors - block the conversion of angiotensin I to angiotensin II. Less vasoconstriction, less aldosterone release, blood pressure drops. ACE also normally degrades bradykinin, so blocking ACE causes bradykinin accumulation - this explains the dry cough side effect.

ARBs (angiotensin receptor blockers) - block angiotensin II receptors. Same blood pressure-lowering effects as ACE inhibitors but without the cough (bradykinin is still degraded normally).

Negative Feedback in RAAS

The RAAS cascade has built-in negative feedback:

  1. When blood pressure normalizes, the JG cells sense adequate pressure and stop releasing renin
  2. Angiotensin II directly inhibits further renin release (short-loop feedback)
  3. Elevated blood pressure activates baroreceptors that suppress sympathetic drive to the JG cells
  4. ANP (released when blood volume is high) inhibits renin, aldosterone, and ADH
A patient takes an ACE inhibitor. What happens to renin, angiotensin I, angiotensin II, and aldosterone levels?
Click to reveal answer
Renin increases (the drop in angiotensin II removes negative feedback on JG cells). Angiotensin I increases (renin is still converting angiotensinogen, but ACE cannot convert AI to AII). Angiotensin II decreases (ACE is blocked). Aldosterone decreases (angiotensin II normally stimulates aldosterone release). Net effect: blood pressure drops.
Why does angiotensin II preferentially constrict the efferent arteriole? What is the physiological purpose?
Click to reveal answer
Efferent constriction maintains GFR even when systemic blood pressure is low. By constricting the "exit" of the glomerulus, blood backs up inside, maintaining glomerular hydrostatic pressure and filtration rate despite reduced renal blood flow. This ensures that waste filtration continues during hypovolemia. However, excessive efferent constriction (e.g., from chronic RAAS activation) can eventually damage the glomerulus.